| Full of Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Reference and Education > Future Concepts > Mensa has Rounded Up Lots of High IQ People; But How Do We Find the Geniuses? |
|
Full of Articles - Mensa has Rounded Up Lots of High IQ People; But How Do We Find the Geniuses?
As the operator of an Online Think Tank it has occurred to me that we need to round up all t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product he geniuses and get rid of the political rhetoric and linear decision making if mankind is t ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in progress forward without being doomed to repeat the past. Of course one of the Internet fou lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ding society noted that; Mensa already did that. And so our online think tank has considered here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe a response and here are some thoughts on this issue. Has Mensa rounded up all the geniuses? d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro No, not really. Have they rounded up all the high IQ humans into their group? Certainly not. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Have they found many 132 IQ plus humans in our civilization and done their due diligence in easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi creening them all? Yes in a way. But the thing is that every the PhD psychologists cannot de nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ine Genius. In fact Creative Geniuses appear to be those over only 120 IQ and higher. So th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t bar is not as high as one might think. An IQ of 120 is not significant in the United State ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi . The key of course is perseverance, as our Internet founders circle had correctly stated pr ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a viously. The enhancement of that elusive to define intelligence can be matched by strength o dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod character and passion to go beyond. Well here is a work in progress of the idea, I am work cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ng on to locate, and network all these superstars of humanity; tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen tank.net/" target="_blank">www.WorldThinkTank.net As you can see have been experimentin t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel with this for some time now. Indeed, I have always found that the stereotype of brilliance ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust r genius is a problem, as folks who are the 100,000th or 1 millionth monkey could be a Plumb y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products r, father of five and perhaps they will live and die without ever giving to the whole of hum . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nity their original thought that could be part of the puzzle to the human struggle. So, are elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ou a genius? Well we know you are out there. I hope this article will propel thought in 2007 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Low Rate Bridging Loans - Get The Dream Property Dealing
|